I'm guessing they'll have a clinical grade one, and one for consumers. Both producing the range of sphygmacor metrics.
From what I been googling there's nothing available today that is comparable, and the health insights it provides are quite significant, I reckon it's a good chance of being disruptive in the field.
General Forum, page-1608
-
- There are more pages in this discussion • 103 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CDX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.88M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 200000 | 5.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.1¢ | 33080 | 1 |
View Market Depth
| Last trade - 16.12pm 13/09/2024 (20 minute delay) ? |
| CDX (ASX) Chart |
Day chart unavailable